View our list of available Coronavirus (COVID-19, SARS-CoV-2, 2019-nCOV) antibodies, recombinant proteins, ELISA Kits... Options Full Datasheet Printer Friendly Datasheet Prepare for Printing Full Datasheet Printer Friendly Datasheet Prepare for Printing Have Questions? Ask Us! Add To Compare List Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) Antigen Catalog # MBS318678 Unit / Price DISCONTINUEDClick here to view our similar product(s) OR click here to contact our technical support team for suitable replacement. Product Name Product Info Accession #s Product Desc Diseases/Tissues/Pathways Applications References Product Name Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1), Antigen Full Product Name Influenza A H1 Peptide Product Synonym Names Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Research Use Only For Research Use Only. Not for use in diagnostic procedures. TOP Host Synthetic Specificity Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Form/Format Purified, Liquid Concentration 0.2mg/ml (lot specific) Buffer PBS, pH 7.2 containing 0.1% BSA Inactivation Not applicable Preservative NaN3 (0.02% Sodium azide) Warning This product contains sodium azide, which has been classified as Xn (Harmful) in European Directive 67/548/EEC in the concentration range of 0.1 - 1.0 %. When disposing of this reagent through lead or copper plumbing, flush with copious volumes of water to prevent azide build-up in drains. Preparation and Storage Store (up to 1 year) at -20 degree C. Avoid multiple freeze/thaw cycles. ISO Certification Manufactured in an ISO 13485:2003 and EN ISO 13485:2012 Certified Laboratory. Other Notes Small volumes of Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) antigen vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply. TOP Related Product Information for Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) antigen Influenza A H1 PeptideInfluenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1)Synthetic peptide corresponding to a region of the hemagglutinin H1 protein from seasonal Influenza A/Brisbane/59/2007 (H1N1). Represents a peptide sequence that is unique from seasonal H1 peptides. For use as a positive control or for blocking the anti-hemagglutinin H1 antibody. Product Categories/Family for Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) antigen Infectious Disease Antigens and Toxins Applications Tested/Suitable for Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) antigen ELISA Application Notes for Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) antigen Suitable for use as a positive control or as a blocking peptide in ELISA. Antibody activity is usually completely blocked by incubating the peptide with an equal volume of antibody for 30 minutes at 37 degree C.Each laboratory should determine an optimum working titer for use in its particular application. Other applications have not been tested but use in such assays should not necessarily be excluded. TOP Precautions All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines. Disclaimer While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information. TOP